Grade Post Therapy Clin (yc)
Notes
**Note 1:** Leave Grade Post Therapy Clin (yc) blank when * No neoadjuvant therapy * Clinical or pathological case only * Neoadjuvant therapy completed, no microscopic exam is done prior to surgery/resection of primary tumor * There is only one grade available and it cannot be determined if it is clinical, pathological, post therapy clinical or post therapy pathological **Note 2:** Assign the highest grade from the microscopically sampled specimen of the primary site following neoadjuvant therapy or primary systemic/radiation therapy. **Note 3:** If there are multiple tumors with different grades abstracted as one primary, code the highest grade. **Note 4:** The grading system for this chapter is based on histology * Immature teratomas and serous carcinomas: Use codes L, H, or 9. This include the following ICD-O-3 codes: 8441/2, 8441/3, 8460/3, 8461/3, 8474/3, 9080/3 * All other histologies: Code 1-3 if a nuclear grade is documented, otherwise code 9 * If your registry collects ovarian borderline tumors (/1), code “B” for grade **Note 5:** G3 includes anaplastic. **Note 6:** Code 9 (unknown) when * Microscopic exam is done after neoadjuvant therapy and grade from the primary site is not documented * Microscopic exam is done after neoadjuvant therapy and there is no residual cancer * Grade checked “not applicable” on CAP Protocol (if available) and no other grade information is availableNAACCR Item
NAACCR #1068Metadata
SSDI| Code | Description |
|---|---|
| 1 | G1: Well differentiated |
| 2 | G2: Moderately differentiated |
| 3 | G3: Poorly differentiated, undifferentiated |
| B | GB: Borderline Tumor |
| L | Low grade |
| H | High grade |
| 9 | Grade cannot be assessed (GX); Unknown |
| <BLANK> | See Note 1 |